INNOVATE CORP. (VATE) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.15%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.15% | Share-based compensation / revenue. Period ending 2026-06-30. $2.20M ÷ $1.52B × 100 ≈ 0.15% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.52B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 2.20M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 64.90M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.52B | $2.20M | $64.90M | (m) | (m) | 0.15% | (m) | (m) |
| 2026-03-31 | (m) | $1.34B | $2.50M | $35.30M | (m) | (m) | 0.19% | (m) | (m) |
| 2025-12-31 | (m) | $1.25B | $2.70M | $28.70M | (m) | (m) | 0.22% | (m) | (m) |
| 2025-09-30 | (m) | $1.10B | $4.50M | $16.90M | (m) | (m) | 0.41% | (m) | (m) |
| 2025-06-30 | (m) | $995.00M | $4.10M | $16.70M | (m) | (m) | 0.41% | (m) | (m) |
| 2025-03-31 | (m) | $1.07B | $3.80M | $40.60M | (m) | (m) | 0.36% | (m) | (m) |
| 2024-12-31 | (m) | $1.11B | $3.40M | $40.00M | (m) | (m) | 0.31% | (m) | (m) |
| 2024-09-30 | (m) | $1.23B | $1.30M | $51.50M | (m) | (m) | 0.11% | (m) | (m) |
| 2024-06-30 | (m) | $1.36B | $1.80M | $56.30M | (m) | (m) | 0.13% | (m) | (m) |
| 2024-03-31 | (m) | $1.42B | $2.10M | $33.30M | $69.80M | (m) | 0.15% | 0.48× | Reported |
| 2023-12-31 | (m) | $1.42B | $2.20M | $26.50M | $68.20M | (m) | 0.15% | 0.39× | Reported |
| 2023-09-30 | (m) | $1.47B | $2.70M | $19.00M | $62.60M | (m) | 0.18% | 0.30× | Reported |
| 2023-06-30 | (m) | $1.52B | $2.30M | $14.90M | $58.80M | (m) | 0.15% | 0.25× | Reported |
| 2023-03-31 | (m) | $1.54B | $2.10M | $8.70M | $55.00M | (m) | 0.14% | 0.16× | Reported |
| 2022-12-31 | (m) | $1.64B | $2.40M | $13.40M | $52.00M | (m) | 0.15% | 0.26× | Reported |
| 2022-09-30 | (m) | $1.62B | $2.40M | $13.80M | $50.90M | (m) | 0.15% | 0.27× | Reported |
| 2022-06-30 | (m) | $1.59B | $2.40M | $8.30M | $50.40M | (m) | 0.15% | 0.16× | Reported |
| 2022-03-31 | (m) | $1.45B | $2.70M | $1.00M | $50.30M | (m) | 0.19% | 0.02× | Reported |
| 2021-12-31 | (m) | $1.21B | $2.40M | $-10.60M | $59.10M | (m) | 0.20% | -0.18× | Reported |
| 2021-09-30 | (m) | $988.40M | $2.10M | $17.00M | $69.80M | (m) | 0.21% | 0.24× | Reported |
| 2021-06-30 | (m) | $764.10M | $2.50M | $-200.00K | $74.90M | (m) | 0.33% | -0.00× | Reported |
| 2021-03-31 | (m) | $702.10M | $2.00M | $-1.40M | $81.60M | (m) | 0.28% | -0.02× | Reported |
| 2020-12-31 | (m) | $716.90M | $2.90M | $-4.10M | $79.40M | (m) | 0.40% | -0.05× | Reported |
| 2020-09-30 | (m) | $1.38B | (m) | $-57.20M | $83.90M | (m) | (m) | -0.68× | Reported |
| 2020-06-30 | (m) | $1.58B | (m) | $-52.00M | $99.90M | (m) | (m) | -0.52× | Reported |
| 2020-03-31 | (m) | $1.68B | (m) | $-23.30M | $97.60M | (m) | (m) | -0.24× | Reported |
| 2019-12-31 | (m) | $1.66B | $7.80M | $29.10M | $95.10M | (m) | 0.47% | 0.31× | Reported |
| 2019-09-30 | (m) | $1.70B | $6.80M | $49.90M | $91.00M | (m) | 0.40% | 0.55× | Reported |
| 2019-06-30 | (m) | $1.75B | $8.00M | $16.00M | $84.50M | (m) | 0.46% | 0.19× | Reported |
| 2019-03-31 | (m) | $1.76B | $9.60M | $-20.40M | $78.70M | (m) | 0.54% | -0.26× | Reported |
| 2018-12-31 | (m) | $1.77B | $9.00M | $-55.80M | $75.70M | (m) | 0.51% | -0.74× | Reported |
| 2018-09-30 | (m) | (m) | $9.34M | $-45.10M | $69.65M | (m) | (m) | -0.65× | Reported |
| 2018-06-30 | (m) | (m) | $7.41M | $-10.19M | $65.42M | (m) | (m) | -0.16× | Reported |
| 2018-03-31 | (m) | (m) | $4.81M | $-15.86M | $60.31M | (m) | (m) | -0.26× | Reported |
| 2017-12-31 | (m) | (m) | $5.24M | $-1.13M | $55.10M | (m) | (m) | -0.02× | Reported |
| 2017-09-30 | (m) | $1.63B | $5.69M | $5.34M | $51.17M | (m) | 0.35% | 0.10× | Reported |
| 2017-06-30 | (m) | $1.64B | $6.11M | $1.63M | $48.67M | (m) | 0.37% | 0.03× | Reported |
| 2017-03-31 | (m) | $1.62B | $6.68M | $18.82M | $47.16M | (m) | 0.41% | 0.40× | Reported |
| 2016-12-31 | (m) | $1.56B | $8.35M | $-1.42M | $43.38M | (m) | 0.54% | -0.03× | Reported |
| 2016-09-30 | (m) | $1.46B | $10.37M | $-8.44M | $41.42M | (m) | 0.71% | -0.20× | Reported |
| 2016-06-30 | (m) | $1.33B | $10.91M | $-15.03M | $41.09M | (m) | 0.82% | -0.37× | Reported |
| 2016-03-31 | (m) | $1.25B | $11.60M | $-17.61M | $40.64M | (m) | 0.93% | -0.43× | Reported |
| 2015-12-31 | (m) | $1.12B | $11.10M | $2.23M | $39.02M | (m) | 0.99% | 0.06× | Reported |
| 2015-09-30 | (m) | $984.09M | $16.70M | $-2.82M | $36.63M | (m) | 1.70% | -0.08× | Reported |
| 2015-06-30 | (m) | $886.05M | $15.08M | $-5.15M | $28.39M | (m) | 1.70% | -0.18× | Reported |
| 2015-03-31 | (m) | $701.66M | $13.48M | $-9.52M | $19.36M | (m) | 1.92% | -0.49× | Reported |
| 2014-12-31 | (m) | $543.20M | $11.49M | $-14.43M | $10.75M | (m) | 2.11% | -1.34× | Reported |
| 2014-09-30 | (m) | $371.57M | $2.27M | $-23.14M | $3.12M | (m) | 0.61% | -7.43× | Reported |
| 2014-06-30 | (m) | $253.22M | $1.81M | $-27.33M | $1.02M | (m) | 0.72% | -26.90× | Reported |
| 2014-03-31 | (m) | $215.25M | $2.00M | $-37.72M | $-4.21M | (m) | 0.93% | (m) | Reported |
| 2013-12-31 | (m) | $230.69M | $2.29M | $-39.14M | $8.00K | (m) | 0.99% | -4892.00× | Reported |
| 2013-09-30 | (m) | (m) | $1.92M | $-5.95M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $2.62M | $-7.76M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $253.44M | $4.01M | $-6.13M | $21.27M | (m) | 1.58% | -0.29× | Reported |
| 2012-12-31 | (m) | $260.55M | $5.19M | $-8.66M | $23.93M | (m) | 1.99% | -0.36× | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $291.39M | $5.22M | $14.90M | $30.81M | (m) | 1.79% | 0.48× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $282.02M | $1.64M | $-5.86M | $35.33M | (m) | 0.58% | -0.17× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TECHPRECISION CORP (TPCS) | United States | $0.053B | 108.37 |
| Proto Labs Inc (PRLB) | United States | $2.226B | 64.02 |
| Arcosa, Inc. (ACA) | United States | $7.195B | 14.51 |
| VALMONT INDUSTRIES INC (VMI) | United States | $8.988B | 22.19 |